By Martinne Geller LONDON (Reuters) - Consumer goods group Reckitt Benckiser is reviewing options for its pharmaceuticals unit, it said on Tuesday, effectively putting up for sale its prescription medicine for heroin addiction, which faces cheap, copycat competition. Shares in the British company rose over 4.5 percent in early trading. Bank of America Merrill Lynch has valued the pharmaceuticals unit at about 2 billion pounds ($3.2 billion). The business centers around the drug Suboxone, which Reckitt sells as a film that dissolves in the mouth. ...
via Health News Headlines - Yahoo! News http://news.yahoo.com/reckitt-benckiser-reviews-pharma-unit-could-sell-085132434--sector.html
No comments:
Post a Comment